| Table 4: |
| Women's Health Initiative Attributable Risk Summary |
|
Excess
Risk per 10,000 Women/Year on Estrogen Plus Progestin |
| 8
more women with breast
cancer 7 more women with coronary artery disease 8 more women with stroke 8 more women with pulmonary embolic |
|
Decreased
Risk per 10,000 Women/Year on Estrogen Plus Progestin |
| 6
fewer women with colorectal
cancer 5 fewer women with hip fractures |
|
Copyright
2003 The Cleveland Clinic Foundation
|
Return to Breast Cancer Risk Assessment and Screening Chapter